To assess the value of the combination of the HOXA9 and HOXA10 promoter CpG methylation markers as a prognostic marker for breast cancer, we performed a multivariate Cox proportional hazards analysis with other subtype markers. Here, HOXA10 is linked to breast carcinoma.